Max A. Milbury - 07 Jul 2022 Form 3 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Principal Accounting Officer
Signature
/s/ Jason L. Langford, Attorney-in-Fact for Max A. Milbury
Issuer symbol
PMN
Transactions as of
07 Jul 2022
Net transactions value
$0
Form type
3
Filing time
07 Jul 2022, 19:25:26 UTC
Next filing
25 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PMN Common Shares 1,700 07 Jul 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PMN Option (right to buy) 07 Jul 2022 Common Shares 8,333 $8.40 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion or exercise price is in Canadian dollars.
F2 The option agreement provides that 1/4 of the options will vest on the one-year anniversary of the grant while the remaining options will vest equally over thirty-six months. The option was granted on February 14, 2022.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney